Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00752596 · ClinicalTrials.gov registry record · Phase 2
Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient
A Phase 2 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00752596 is a Phase 2 study that has completed, run by Forest Laboratories. The registered enrollment target is 1 participants.
The verdict
NCT00752596, a Phase 2 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is an open-label, long term compassionate use study of 125 mg per day of azimilide 2HCl in a patient who completed two other protocols (2000098 and 2001060.
Interventions
- DRUG Azimilide 2HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00752596
The ClinicalTrials.gov registry entry for NCT00752596 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Azimilide 2HCl is the first listed.
NCT00752596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00752596 about?
NCT00752596 is a clinical study titled "Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient". This is an open-label, long term compassionate use study of 125 mg per day of azimilide 2HCl in a patient who completed two other protocols (2000098 and 2001060.
What is the current status of trial NCT00752596?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2005-09. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00752596?
The interventions under investigation include: Azimilide 2HCl (DRUG).
Who is sponsoring clinical trial NCT00752596?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.